The results — according to a study carried out from May perhaps to December 2022 — also show, having said that, that these executives and consultants want more info about the drugs’ extra overall health benefits to warrant the large Value prior to featuring protection for their workforce.Eli Lilly, the maker of diabetes drug Mounjaro, is pred